Danone (DN) CME 2024 summary

Strategic transformation and future direction

• Over the past two years, a radical transformation was executed, renewing governance, leadership, and instilling a performance-driven, science-led culture focused on operational excellence and long-term value creation.

• The company shifted from a local-first to a Danone-first culture, leveraging a glocal model for global brands and local execution, and prioritized accountability and interdependence.

• Portfolio management included divesting 9% of revenues, pruning non-strategic assets, and refocusing on high-value segments, with targeted acquisitions aligned with health and nutrition priorities.

• Sustainability is a strategic business driver, with leading initiatives in methane reduction, regenerative agriculture, water preservation, and low-methane dairy.

• Investments in brand support, innovation, and capabilities have been scaled up, with €300m in A&P and €200m each in operations and innovation since 2021.

Growth engines and category opportunities

• Health through food is central, with 89% of volumes from products scoring 3.5+ HSR, and a focus on aging populations and chronic diseases.

• Major growth opportunities are in Medical Nutrition, protein-rich dairy, gut health, and plant-based, with Medical Nutrition expected to grow by 50% and protein-rich yogurt/desserts delivering double-digit growth.

• The company is expanding into new channels such as home care and away-from-home consumption, and scaling double-digit growth platforms to €8bn.

• Geographic expansion is targeted in the U.S., India, Southeast Asia, and China, while maintaining leadership in Europe.

• Innovation is driven by science, with a streamlined pipeline focused on fewer, larger projects, and a disciplined superiority program to ensure product excellence.

Financial guidance and value creation

• 2025–2028 guidance targets like-for-like sales growth of +3% to +5% annually, with recurring operating income growing faster than net sales.

• Free cash flow ambition is set structurally toward €3 billion, up from €2.6 billion, with a commitment to double-digit ROIC.

• Margin expansion is to be driven by volume-led growth, operating leverage, and productivity, with EDP and Waters targeted for sustainable double-digit margins.

• Capital allocation prioritizes growth investments, accretive M&A, and maintaining leverage within 2x–3x EBITDA, while adhering to a progressive dividend policy.

• Incentives are aligned with value creation, including metrics such as sales, margin, free cash flow, EPS, and ROIC.